Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Graeme A. Fenton
Observed names:
Fenton, Graeme,
Graeme A Fenton,
Graeme Fenton
Institutions:
University of Maryland, Baltimore,
University of Maryland Medical Center
Observed institutions:
University of Maryland, Baltimore,
University of Maryland Medical Center,
University of Florida Health,
University of Florida,
University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
ORCID:
0000-0002-6418-1221
Observed ORCID:
0000-0002-6418-1221
OpenAlex ID:
A5008280339
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
2024
·
Vrunda Trivedi
, Changlin Yang
, et al.
·
Genome Medicine
·
69
PDF
Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic
2022
·
Graeme A. Fenton
, Duane A. Mitchell
·
Clinical Cancer Research
·
26
Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study
2023
·
Kriti Gera
, Doga Kahramangil
, et al.
·
Cancers
·
13
PDF
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
2025
·
Bingnan Zhang
, Laura Alder
, et al.
·
Lung Cancer
·
7
Brief Report: Multi-Institution Real-World Analysis Evaluating Safety, Efficacy, and ctDNA Dynamics After Tarlatamab in Patients With Previously Treated SCLC and LCNEC
2025
·
Graeme Fenton
, Annie L. Zhang
, et al.
·
JTO Clinical and Research Reports
·
6
PDF
Exacerbations of Persistent Neurotoxicity following Axicabtagene Ciloleucel in a Patient with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Case Report
2024
·
Graeme A. Fenton
, Erin A. Dean
·
Case Reports in Oncology
·
2
PDF
Predictors of Rehabilitation Utilization After CAR T-Cell Therapy
2026
·
Hanan Alharthy
, Abdulaziz Abu-Haimed
, et al.
·
Transplantation and Cellular Therapy
·
1
Predictive markers of response and toxicity to tarlatamab in patients with extensive stage small cell lung cancer (ES-SCLC): A multi-institutional real-world analysis.
2026
·
Graeme Fenton
, Daniel Hess
, et al.
·
Journal of Clinical Oncology
·
1
Central nervous system manifestations as initial presentation of plasma cell disorders: Differential management of 3 cases based on disease extent
2023
·
Kyle McGrath
, Graeme A. Fenton
, et al.
·
Current Problems in Cancer Case Reports
·
1
Exth-44. Personalized Immunotherapy Vaccines for Glioblastoma and Their Treatment Efficacy
2022
·
Vrunda Trivedi
, Changlin Yang
, et al.
·
Neuro-Oncology
·
1
PDF
Predictive markers of response and toxicity to tarlatamab in patients with extensive stage small cell lung cancer: a multi-institutional real-world analysis
2026
·
Graeme Fenton
, Wanru Guo
, et al.
·
medRxiv
PDF
Tarlatamab CRS and ICANS Risk Calculator
2026
·
Guo, Wanru
, Fenton, Graeme
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
CAR-T cell Therapy Following Allogeneic Stem Cell Transplant: Clinical Outcomes and Toxicity Profile from a Single-Center Retrospective Cohort
2026
·
Graeme A. Fenton
, Emily Davidson
, et al.
·
Transplantation and Cellular Therapy
Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological complications in chimeric antigen receptor T-cell therapy—A retrospective analysis
2026
·
Melissa A Nicholas
, Abdulaziz Abu-Haimed
, et al.
·
Neuro-Oncology Advances
Rapidly progressive adult-onset hydroa vacciniforme-like lymphoproliferative disorder associated with Epstein-Barr virus: a case report
2026
·
Joseph Deng
, Gideon Wolf
, et al.
·
Leukemia Research Reports
Impact and predictors of icans on survival in lymphoma and myeloma patients treated with CAR T cell therapy
2025
·
Abdulaziz Abu-Haimed
, Olga Goloubeva
, et al.
·
Blood
Rehabilitation needs and predictors of functional outcomes following CAR T-cell therapy in lymphoma and multiple myeloma
2025
·
Hanan Alharthy
, Abdulaziz Abu Haimed
, et al.
·
Blood
PDF
Atypical neurotoxicity in CAR-T cell therapy: A retrospective analysis of unusual icans presentations and their clinical implications
2025
·
Melissa Nicholas
, Abdulaziz Abu Haimed
, et al.
·
Blood
Immu-33. Precision Antigen-directed Immunotherapy Treatment of Brain Tumors Increases Tumor-infiltrating Effector Lymphocyte Responses
2023
·
Vrunda Trivedi
, Changlin Yang
, et al.
·
Neuro-Oncology
PDF
Central nervous system nocardiosis mimicking recurrence of diffuse large B cell lymphoma with cerebral involvement
2023
·
Graeme A. Fenton
, Grant Banfill
, et al.
·
International Journal of Infectious Diseases
PDF
Abstract 5114: Development of personalized RNA-based immunotherapeutics for glioblastom
2023
·
Vrunda Trivedi
, Changlin Yang
, et al.
·
Cancer Research
Show more works
View as search
Works count:
21
Citation count:
127
H-index:
5
I10-index:
3
Year
Topic
Type